Epigenetic inactivation of the NORE1 gene correlates with malignant progression of colorectal tumors

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Lee, Chang K ^a   Lee, Jin Hee ^b   Lee, Min Goo ^b   Jeong, Seong In ^b   Ha, Tae Kyu ^b   Kang, Min Ju ^b   Ryu, Byung Kyu ^b   Hwangbo, Young ^a   Shim, Jae Jun ^a   Jang, Jae Y ^a   Lee, Kil Y ^a   Kim, Hyo J ^a   Chi, Sung Gil ^b  

^a Kyung Hee University Hospital   (South Korea)

^b Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BISULFITE; COMPLEMENTARY DNA; PROTEIN NORE1A; PROTEIN NORE1B; RAS PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; RASSF5 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER STAGING; CELL COUNT; COLON MUCOSA; COLONY FORMATION; COLORECTAL TUMOR; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; EPIGENETICS; FLOW CYTOMETRY; GENE INACTIVATION; GENETIC ASSOCIATION; GENETIC CORRELATION; HUMAN; HUMAN CELL; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIMARY TUMOR; PROMOTER REGION; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC MUTATION; TRANSIENT EXPRESSION; TUMOR GROWTH; CELL PROLIFERATION; CELL STRAIN CACO 2; DISEASE COURSE; GENETIC EPIGENESIS; GENETICS; METHODOLOGY; NUCLEOTIDE SEQUENCE; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CACO-2 CELLS; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; CPG ISLANDS; DISEASE PROGRESSION; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; EPIGENESIS, GENETIC; FLOW CYTOMETRY; GENES, TUMOR SUPPRESSOR; HUMANS; MONOMERIC GTP-BINDING PROTEINS; SEQUENCE ANALYSIS, DNA;

EID: 77958028823     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-577     Document Type: Article

References (32)

1. Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ, Der CJ. Increasing complexity of Ras signaling. Oncogene 1998, 17:1395-413. 10.1038/sj.onc.1202174, 9779987.
2. Downward J. The ins and outs of signalling. Nature 2001, 411:759-762. 10.1038/35081138, 11459043.
3. Malumbres M, Pellicer A. RAS pathways to cell cycle control and cell transformation. Front Biosci 1998, 3:d887-d912.
4. Rommel C, Hafen E. Ras - a versatile cellular switch. Curr Opin Genet Dev 1998, 8:412-418. 10.1016/S0959-437X(98)80111-1, 9729716.
5. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000, 25:315-319. 10.1038/77083, 10888881.
6. Ponting CP, Benjamin DR. A novel family of Ras-binding domains. Trends Biochem Sci 1996, 21:422-425. 10.1016/S0968-0004(96)30038-8, 8987396.
7. van der Weyden L, Adams DJ. The Ras-association domain family (RASSF) members and their role in human tumorigenesis. Biochim Biophys Acta 2007, 1776:58-85. 2586335,2586335, 17692468.
8. Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, Fong K, Gao B, Randle D, Kondo M, Virmani A, Bader S, Sekido Y, Latif F, Milchgrub S, Toyooka S, Gazdar AF, Lerman MI, Zabarovsky E, White M, Minna JD. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 2001, 93:691-699. 10.1093/jnci/93.9.691, 11333291.
9. Agathanggelou A, Honorio S, Macartney DP, Martinez A, Dallol A, Rader J, Fullwood P, Chauhan A, Walker R, Shaw JA, Hosoe S, Lerman MI, Minna JD, Maher ER, Latif F. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene 2001, 20:1509-1518. 10.1038/sj.onc.1204175, 11313894.
10. Dammann R, Yang G, Pfeifer GP. Hypermethylation of the CpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res 2001, 61:3105-3109.
11. Lo KW, Kwong J, Hui AB, Chan SY, To KF, Chan AS, Chow LS, Teo PM, Johnson PJ, Huang DP. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 2001, 61:3877-3881.
12. Vos MD, Ellis CA, Bell A, Birrer MJ, Clark GJ. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J Biol Chem 2000, 275:35669-35672. 10.1074/jbc.C000463200, 10998413.
13. Vavvas D, Li X, Avruch J, Zhang XF. Identification of Nore1 as a potential Ras effector. J Biol Chem 1998, 273:5439-5442. 10.1074/jbc.273.10.5439, 9488663.
14. Tommasi S, Dammann R, Jin SG, Zhang XF, Avruch J, Pfeifer GP. RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1. Oncogene 2000, 21:2713-2720.
15. Hesson L, Dallol A, Minna JD, Maher ER, Latif F. NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers. Oncogene 2003, 22:947-954. 10.1038/sj.onc.1206191, 12584574.
16. Chen J, Lui WO, Vos MD, Clark GJ, Takahashi M, Schoumans J, Khoo SK, Petillo D, Lavery T, Sugimura J, Astuti D, Zhang C, Kagawa S, Maher ER, Larsson C, Alberts AS, Kanayama HO, Teh BT. The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas. Cancer Cell 2003, 4:405-413. 10.1016/S1535-6108(03)00269-1, 14667507.
17. Aoyama Y, Avruch J, Zhang XF. Nore1 inhibits tumor cell growth independent of Ras or the MST1/2 kinases. Oncogene 2004, 23:3426-3433. 10.1038/sj.onc.1207486, 15007383.
18. Vos MD, Martinez A, Ellis CA, Vallecorsa T, Clark GJ. The proapoptotic Ras effector Nore1 may serve as a Ras-regulated tumor suppressor in the lung. J Biol Chem 2003, 278:21938-21943. 10.1074/jbc.M211019200, 12676952.
19. Geli J, Kiss N, Lanner F, Foukakis T, Natalishvili N, Larsson O, Kogner P, Höög A, Clark GJ, Ekström TJ, Bäckdahl M, Farnebo F, Larsson C. The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma. Endocr Relat Cancer 2007, 14:125-134. 10.1677/ERC-06-0031, 17395981.
20. Ortiz-Vega S, Khokhlatchev A, Nedwidek M, Zhang XF, Dammann R, Pfeifer GP, Avruch J. The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1. Oncogene 2002, 21:1381-1390. 10.1038/sj.onc.1205192, 11857081.
21. Calvisi DF, Donninger H, Vos MD, Birrer MJ, Gordon L, Leaner V, Clark GJ. NORE1A tumor suppressor candidate modulates p21CIP1 via p53. Cancer Res 2009, 69:4629-4637. 10.1158/0008-5472.CAN-08-3672, 19435914.
22. Zhou CZ, Qiu GQ, Zhang F, He L, Peng ZH. Loss of heterozygosity on chromosome 1 in sporadic colorectal carcinoma. World J Gastroenterol 2004, 10:1431-1435.
23. Ragnarsson G, Eiriksdottir G, Johannsdottir JT, Jonasson JG, Egilsson V, Ingvarsson S. Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival. Br J Cancer 1999, 79:1468-1474. 10.1038/sj.bjc.6690234, 2362732, 10188892.
24. Ehrlich M, Jiang G, Fiala E, Dome JS, Yu MC, Long TI, Youn B, Sohn OS, Widschwendter M, Tomlinson GE, Chintagumpala M, Champagne M, Parham D, Liang G, Malik K, Laird PW. Hypomethylation and hypermethylation of DNA in Wilms tumors. Oncogene 2002, 21:6694-6702. 10.1038/sj.onc.1205890, 12242669.
25. Sato F, Meltzer SJ. CpG island hypermethylation in progression of esophageal and gastric cancer. Cancer 2006, 106:483-493. 10.1002/cncr.21657, 16362978.
26. Akino K, Toyota M, Suzuki H, Mita H, Sasaki Y, Ohe-Toyota M, Issa JP, Hinoda Y, Imai K, Tokino T. The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer. Gastroenterology 2005, 129:156-169. 10.1053/j.gastro.2005.03.051, 16012945.
27. Irimia M, Fraga MF, Sanchez-Cespedes M, Esteller M. CpG island promoter hypermethylation of the Ras-effector gene NORE1A occurs in the context of a wild-type K-ras in lung cancer. Oncogene 2004, 23:8695-8699. 10.1038/sj.onc.1207914, 15378027.
28. Bird AP, Wolffe AP. Methylation-induced repression-belts, braces, and chromatin. Cell 1999, 99:451-454. 10.1016/S0092-8674(00)81532-9, 10589672.
29. Ng HH, Bird A. DNA methylation and chromatin modification. Curr Opin Genet Dev 1999, 9:158-163. 10.1016/S0959-437X(99)80024-0, 10322130.
30. Kondo Y, Issa JP. Epigenetic changes in colorectal cancer. Cancer Metastasis Rev 2004, 23:29-39. 10.1023/A:1025806911782, 15000147.
31. Neibergs HL, Hein DW, Spratt JS. Genetic profiling of colon cancer. J Surg Oncol 2002, 80:204-213. 10.1002/jso.10131, 12210035.
32. Kim KM, Shibata D. Methylation reveals a niche: stem cell succession in human colon crypts. Oncogene 2002, 21:5441-5449. 10.1038/sj.onc.1205604, 12154406.